For decades, UK general practice IT was a quiet market. Two dominant suppliers — EMIS Web and TPP SystmOne — held virtually the entire market. Switching systems was painful, expensive, and operationally risky. The result was stability for incumbents and limited choice for practices.
That stability is now under pressure from multiple directions simultaneously — and Doctolib's acquisition of Medicus is the most dramatic signal yet.
The Incumbent Position
EMIS Web and TPP SystmOne are not simply software products. They are deeply embedded in the operational infrastructure of UK general practice. Every prescription, every referral, every appointment, every clinical note, every QOF submission, every task, every document — all flow through the core GP IT system. Switching systems means migrating millions of patient records, retraining entire clinical teams, reconnecting with every NHS service integration, and accepting weeks of operational disruption during the transition.
This switching cost is the incumbents' moat. It is not product superiority that keeps practices on EMIS or SystmOne — it is the practical impossibility of switching without significant operational risk. NHS England's own framing acknowledged this: GP practices had "largely had a choice of just two suppliers" for the systems they use to manage patient care.
NHS England Wants Change
The approval of Medicus through the Tech Innovation Framework in June 2025 was an explicit policy signal. NHS England described it as "the first shake-up of the GP IT market in a quarter of a century" and stated that more suppliers meeting the Framework's standards were expected by April 2026. The language was deliberate — "reforms to increase competition and innovation" — signalling that the duopoly is viewed as a structural problem, not a market equilibrium.
More than 25 Integrated Care Boards were exploring adoption pathways by mid-2025. The direction of travel is clear: NHS England wants practices to have genuine choice in their clinical systems, and is actively creating the regulatory and procurement frameworks to enable it.
Medicus Proved the Gate Can Be Opened
Medicus Health's achievement was not building a better GP system — that is a product question. Its achievement was passing the assurance gate. The Tech Innovation Framework ensures compliance with information governance, clinical safety (DCB 0129), data protection, and integration with national infrastructure — EPS, eRS, NHS App, PDS, SCR. Medicus integrated with 24 national NHS services and implemented five new national open standards for information exchange.
This assurance process is the real barrier to entry. Any new GP IT supplier must navigate the same framework — which requires years of development, testing, clinical safety assessment, and integration engineering. Medicus proved it can be done. Doctolib has now acquired the company that did it.
Doctolib Brings Capital, Product Experience, and European Scale
Doctolib is not a startup experimenting with the UK market. It is Europe's largest digital health platform — 520,000 health professionals, 90 million patients, operational across France, Germany, and Italy, with €348 million in annual recurring revenue and a reported valuation exceeding €6 billion.
The reported £100 million UK push, 150 UK hires, and London R&D centre suggest a strategic commitment, not a pilot. Doctolib has prior experience entering new European markets through acquisition — it acquired Dottori.it for Italian market entry, Siilo for Dutch messaging, Aaron.ai for German AI telephone reception, and Typeless for speech recognition. The Medicus acquisition follows the same playbook: buy local regulatory clearance and clinical credibility, then invest heavily in growth.
The Real Prize: The Integrated Clinical Desktop
The strategic question is not whether Doctolib can build a better booking system or a faster scribe. It is whether Doctolib can build the integrated clinical desktop — the single environment where appointments, consultations, documentation, prescribing, referrals, messaging, and AI-assisted decision support converge.
This is the vision Doctolib's leadership has articulated: "an operating system for doctors." Medicus gives them the regulated UK foundation. Aaron.ai gives them AI-powered access. Typeless gives them speech-to-text. The components are assembling.
For practices considering adoption, the question is whether Doctolib can deliver operational reliability, clinical safety, and NHS integration at the standard that EMIS and SystmOne have maintained for decades. Regulatory clearance is necessary but not sufficient — practices need the system to work reliably, every day, for every patient.
What This Means for Clinical AI Tools
The more EHR competition there is, the more the market needs modular clinical knowledge tools that are not locked into one vendor's ecosystem. A practice using EMIS should have the same access to clinical evidence tools as a practice using Medicus or SystmOne. A clinician switching systems should not lose their clinical knowledge workflow.
iatroX is positioned for this modular future: guideline-grounded clinical answers, calculators, exam preparation, and CPD — independent of any EHR vendor, portable across workflows, and designed for the clinician rather than the system.
The GP IT market is opening up. The clinical knowledge layer should be open too.
Try Ask iatroX — clinical knowledge that works across systems →